Related Experiment Video

Updated: Jun 5, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Management of infants born to mothers with gestational diabetes. Paediatric environment

D Mitanchez1

  • 1Université Pierre et Marie Curie, Faculté de médecine, Pôle de périnatalité, Service de néonatologie, AP-HP, Hôpital Armand Trousseau, 75571 Paris cedex 12, France. delphine.mitanchez@trs.aphp.fr

Diabetes & Metabolism
|December 18, 2010
PubMed

Insights

Newborns of mothers with gestational diabetes mellitus (GDM) generally do not require specialized care unless there are severe complications. Standard monitoring protocols for blood glucose and other clinical signs are crucial for managing GDM infants.

Area of Science:

  • Neonatal care
  • Maternal-fetal medicine
  • Endocrinology

Background:

  • Gestational diabetes mellitus (GDM) affects maternal and neonatal health.
  • Optimal neonatal care strategies for GDM infants require clear guidelines.

Purpose of the Study:

  • To evaluate neonatal care modalities for infants born to mothers with treated and untreated gestational diabetes mellitus.
  • To establish evidence-based recommendations for managing these newborns.

Main Methods:

  • Systematic literature search of PubMed.
  • Consultation of guidelines from National Institute for Health and Clinical Excellence and French National Authority for Health.

Main Results:

  • Specialized neonatal care is only indicated for severe fetal abnormalities, major malformations, or risk of preterm birth.
  • Systematic blood glucose monitoring is recommended for infants of insulin-treated GDM mothers or those with growth abnormalities.
  • Routine monitoring for icterus and clinical assessment for calcium levels, CBC, and congenital defects are advised.

Conclusions:

  • Newborns of mothers with GDM can typically be cared for in general maternity wards.
  • Written protocols improve the management of GDM infants, especially regarding hypoglycemia prevention and detection.
Abstract

More Related Videos

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...